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Summary 
The signal recognition particle (SRP) binds to ribo- 
somes that synthesize nascent chains bearing signal 
sequences and catalyzes their targeting to the endo- 
plasmic reticulum membrane. In S. cerevisiae, a tem- 
perature-sensitive mutation in the SEC65 gene, encod- 
ing an SRP subunit, results in lowered levels of SRP. 
Growth and protein translocation defects induced by 
this mutation can be suppressed specifically by suble- 
thal doses of cycloheximide but not anisomycin, each 
inhibitors of different steps of translation elongation. 
Cycloheximide also suppresses protein translocation 
defects caused by depletion of a different SRP subunit. 
We propose that reduced elongation rates in the pres- 
ence of cycloheximide allow otherwise insufficient 
SRP to interact efficiently with ribosomes. These re- 
sults are consistent with a sampling model in which 
SRP cycles on and off of translating ribosomes at spe- 
cific steps during the elongation cycle to inspect all 
nascent chains for the presence of signal sequences. 
Introduction 
The signal recognition particle (SRP) is a cytosolic ribo- 
nucleoprotein that selects ribosomes synthesizing mem- 
brane and secretory proteins and targets these ribosome- 
nascent chain complexes to the endoplasmic reticulum 
(ER) membrane (for review, see Walter and Johnson, 
1994). Selection involves the binding of SRP to signal se- 
quences as they emerge as part of the nascent chain from 
the ribosome. As a consequence of this interaction, SRP 
binds more tightly to the ribosome-nascent chain com- 
plex, and the elongation of the nascent protein chain 
pauses (elongation arrest), suggesting that SRP interacts 
directly with the ribosome (Wolin and Walter, 1989). Upon 
targeting of the SRP-ribosome-nascent chain complex 
to the ER membrane, the interaction of the SRP with the 
SRP receptor, an ER membrane protein, displaces SRP in 
a GTP-dependent reaction from both the signal sequence 
and the ribosome (Connolly et al., 1991 ; Miller et al., 1993). 
Released from SRP, the ribosome engages with the pro- 
tein translocation apparatus in the ER membrane, transla- 
tion resumes, and, concomitant with its synthesis, the na- 
scent protein chain is translocated across or, in the case 
of an integral membrane protein, integrated into the ER 
membrane. Thus, SRP can be viewed as an adapter be- 
tween the protein translation machinery in the cytosol and 
protein translocation machinery in the ER membrane that 
ensures that selection and targeting of ribosomes synthe- 
sizing signal sequence-bearing nascent chains occurs in 
a cotranslational manner. 
Much of this model describing SRP function was derived 
from biochemical studies of mammalian SRP. Recently, 
structurally similar SRP and SRP receptor homologs from 
the yeast Saccharomyces cerevisiae have been identified 
and shown to function in protein translocation in vivo 
(Brown et al., 1994; Hann et al., 1989; Ogg et al., 1992; 
Stirling and Hewitt, 1992). Deletio0 of the genes encoding 
any SRP or SRP receptor component leads to identical 
phenotypes: slow cell growth and inefficient protein trans- 
location across the ER membrane. In the absence of SRP, 
the efficiency with which proteins are translocated across 
the ER differs among individual proteins: the translocation 
of some proteins is severely impaired, while some others 
are not affected at all (Hann and Walter, 1991). Because of 
this observation and because yeast cells can grow, albeit 
slowly, in the absence of SRP, there must be an alterna- 
tive, SRP-independent route by which proteins can be 
translocated across the ER membrane in cells lacking 
SRP. In vitro studies have shown that protein translocation 
across ER-derived 'membranes can occur posttransla- 
tionally (Hansen et al., 1986; Rothblatt and Meyer, 1986; 
Waters and Blobel, 1986), and hence it is plausible that 
in yeast, SRP-dependent cotranslational and SRP- 
independent posttranslational pathways coexist that are, 
at least in part, functionally redundant. 
SRP homologs have been identified in all cells analyzed 
to date, including bacteria, archae, and eukaryotes. In 
Escherichia coil, the SRP consists of a single protein sub- 
unit, Ffh, that is homologous to the eukaryotic Srp54 pro- 
tein, the SRP subunit that binds to signal sequences, and 
a small RNA, 4.5S RNA, that shares a structurally similar 
domain with eukaryotic SRP RNA. There is increasing evi- 
dence that these structurally related bacterial RNPs func- 
tion like their eukaryotic counterparts in signal sequence 
recognition and protein targeting (Wolin, 1994). As in S. 
cerevisiae, an SRP-independent targeting pathway can 
operate in E. coil; but in contrast with yeast, this pathway 
cannot sustain life in the absence of the SRP. 
The evolutionary conservation of SRP suggests that its 
function must be important. One explanation is that the 
cotranslational nature of the signal recognition event by 
SRP guarantees that nascent chains are targeted to the 
appropriate membrane early during their synthesis, i.e., 
before too much of the protein has been synthesized. This 
may assure targeting of short nascent chains that can be 
efficiently translocated before they, after further elonga- 
tion, may have had the opportunity to misfold or aggregate 
into a translocation-incompetent state in the cytosol. Here, 
we present evidence thatthe function of SRP early in the 
synthesis of a protein is assured through a mechanism 
where the ribosome plays a direct role in the signal recog- 
nition event. In particular, we show that the interaction of 
SRP with the ribosome is obligatory for SRP function in 
vivo. Furthermore, our data suggest that the SRP-ribo- 
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some interaction is restricted to a defined state in the elon- 
gation cycle of the ribosome. Taken together, our results 
point at a much more intimate and exquisitely regulated 
interaction between SRP and ribosomes than previously 
appreciated. 
Results 
SEC65 encodes the yeast homolog of mammalian SRP19, 
an essential component of SRP (Stirling and Hewitt, 1992). 
The gene was identified genetically and cloned by comple- 
mentation of the recessive sec65-1 mutation, which ren- 
ders yeast cells temperature sensitive for growth (Stirling 
et al., 1992). We mapped the mutation responsible for the 
temperature-sensitive phenotype to a C to T transition that 
results in a change of Pro-152 (CC__A) to leucine (CTA) (see 
Experimental Procedures). As previously shown, this mu- 
tation causes Sec65p to be unstable at the nonpermissive 
temperature, causing SRP in these cells to be partially 
disrupted (Hann et al., 1992). Surprisingly, yeast cells 
bearing the sec65-1 mutation not only show growth arrest, 
but also die when incubated at the nonpermissive temper- 
ature. In contrast, cells bearing a complete disruption of 
SEC65 are viable, although, like cells in which genes en- 
coding other SRP components are disrupted, they have 
growth and protein translocation defects. Thus, it seems 
a paradox that sec65-1 cells are conditionally lethal, yet 
cells bearing the SEC65 gene disruption are viable. 
--To test whether the temperature-sensitive phenotype of 
sec65-1 cells is related to SRP function or is due to some 
indirect interference of mutant Sec65p with some essen- 
tial cellular process, we constructed strain SOY288 (see 
Table 1), bearing both a disruption of the gene encoding 
SRP RNA (scrl/t) and the sec65-1 mutation (see Experi- 
mental Procedu res). Growth analyses showed that SOY288 
cells were not temperature sensitive: cells grew at the rate 
characteristic for SRP-depleted cells at both 24°C and 
37°C, the permissive and nonpermissive temperatures for 
sec65-1 (Figure 1). Transformation with a plasmid bearing 
the wild-type SCR1 gene complemented the growth de- 
fects and restored the temperature-sensitive phenotype. 
We infer from these data that the temperature-sensitive 
phenotype of the sec65-1 mutation is manifested only in 
cells that contain SRP; i.e., cells that lack S RP are immune 
to the detrimental effects of the sec65-1 mutation at the 
nonpermissive temperature. This result suggests that the 
temperature-induced disruption of the mutant SRP directly 
causes cell death. 
A possible explanation for the paradox described above 
is that yeast cells are sensitive to the kinetics with which 
SRP is lost: as SRP levels drop suddenly when sec65-I 
cells are shifted to the nonpermissive temperature, cells 
might not have enough time to switch over to an SRP- 
independent mode of protein targeting. This failure to 
adapt would result in cell death. This model suggests that 
it might be possible to suppress the temperature-sensitive 
phenotype of the sec65-1 mutation first of all if SRP- 
independent targeting were enhanced, second, if SRP lev- 
els at the nonpermissive temperature were stabilized, or 
third, if an insufficient SRP concentration present in 
sec65-1 cells at the nonpermissive temperature could be 
made to suffice. 
To explore these possibilities, we pursued the observa- 
tion, first made by D. Feldheim and R. Schekman, that 
sublethal concentrations of cycloheximide, an inhibitor of 
translation elongation, can suppress the temperature- 
sensitive growth defect of sec65-1 cells. To demonstrate 
suppression, a lawn of sec65-1 cells was plated on yeast 
extract-peptone-dextrose (YEPD, or yeast complete me- 
dia) plates and filter disks soaked either in water (Figure 
2A, minus CHX) or in a cycloheximide solution (Figure 2A, 
plus CHX) were placed in the center of the plates. When 
plates were incu bated at 37°C, a distinct ring of cell growth 
was observed surrounding the filter disk that contained 
cycloheximide (Figure 2A, bottom right), whereas no cells 
grew on the plate containing the disk soaked in water (Fig- 
ure 2A, bottom left). The diameter of this ring was depen- 
dent on the amount of cycloheximide added to the filter 
disk: higher amounts produced a ring with a larger diame- 
ter, whereas lower amounts produced a ring with~a smaller 
diameter (data not shown). The most plausible interpreta- 
tion of these results is that, during the incubation time, 
cycloheximide diffuses from the disk and forms a radially 
symmetric concentration gradient. Within a narrow con- 
centration range, cycloheximide suppresses the growth 
defect of sec65-1 cells at the nonpermissive temperature, 
resulting in a ring of cell growth. 
To quantitate this result, we measured the growth rate 
of sec65-1 cells in liquid culture at different cycloheximide 
concentrations at 24°C and 37°C (Figure 2B). In agree- 
24 °C 37 °C 37 °C 
scrl::HIS3 
SEC65 
scrl::HIS3 scrI::HIS3 scrl::HIS3 scrl::HIS3 
sec65-1 SEC65 sec65-1 SEC65 
pSCR1 
scrl::HIS3 
sec65-1 
pSCR1 
Figure 1. Intact SRP Is Required for sec65-1 
Cells to Manifest the Temperature-Sensitive 
Defect 
Cells with the indicated relevant genotype 
(SOY288 (scr1::HIS3, sec65-I) and BHY132 
(scr1::HIS3, SEC65) were streaked onto YEPD 
plates and incubated at the indicated tempera- 
tures (left and middle plates). Both strains were 
transformed with pSQR1, a plasmid containing 
the wild-type SCR1 sequence, streaked onto 
a YEPD plate, and incubated at 37°C (right 
plate). 
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Figure 2. Cycloheximide, but Not Anisomycin, Suppresses the Tern- 
perature-Sensitive Defect of sec65-1 Cells 
(A) Cells (RSY457, sec65-1) were plated on YEPD plates. Filter disks 
containing 6 nmol of cycloheximide (in water) were placed in the center 
of each plate (plus CHX). Filter disks containing only water serve as 
the control (minus CHX). Plates were incubated at the indicated tem- 
peratures for three days. 
(B and C) Cells were grown in liquid YEPD medium containing the 
indicated amount of cycloheximide at 24°C (open squares) or 37°C 
(closed circles). Growth rates were determined by measuring the OD~ 
of the cultures. Each data point represents the average of two experi- 
ments. (B) shows the growth rates for strain RSY457 (sec65-1, CYH2), 
and (C), the growth rates for strain SOY158 (sec65-I, cyh2). 
(D) RSY457 (sec65-1) cells were grown in the presence of anisomycin 
at 24°C (open squares) or 37°C (closed circles). 
ment with the plate assay, addition of low concentrations of 
cycloheximide resulted in cell growth at the nonpermissive 
temperature. The growth rate was maximal at 0.4 p.M 
cycloheximide and, at this concentration, was identical at 
the permissive and nonpermissive temperature. Cyclo- 
heximide concentrations in excess of 0.4 ~M inhibited the 
growth rate equally at either temperature, presumably be- 
cause the rate of translation became limiting for cell 
growth. 
sec65-1 cells show marked protein translocation defects 
upon shift to the nonpermissive temperature (Stirling and 
Hewitt, 1992; Stirling et al., 1992). To ask whether cyclo- 
heximide suppresses the protein translocation defects in 
addition to the growth defect, we pulse labeled sec65-1 
cells with [z~S]methionine, ither at 24°C or 37°C, and in 
the presence or absence of 0.4 I~M cycloheximide. Using 
antibodies that recognize Kar2p or DPAP-B, two proteins 
that use the SRP-dependent protein-targeting pathway to 
the ER membrane, we performed immunoprecipitation re- 
actions from extracts of the radiolabeled cells. Accumu- 
lated precursor forms of both Kar2p and DPAP-B were 
significantly increased when sec65-1 cells were shifted to 
the nonpermissive temperature (see Figure 3; compare 
lane 3 with lane 1). Translocation defects in Kar2p are 
indicated by the accumulation of a more slowly migrating 
band, pre-Kar2p, containing an uncleaved signal se- 
quence, whereas translocation defects of DPAP-B result in 
the accumulation of a faster-migrating band, pre-DPAP-B, 
lacking N-linked glycosylation. The addition of 0.4 I~M 
cycloheximide completely abolished precursor accumula- 
tion of both Kar2p and DPAP-B at the nonpermissive tem- 
perature. Thus, both cell growth and protein translocation 
defects manifested in sec65-1 cells at the nonpermissive 
temperature are suppressed by cycloheximide. 
Cyclohexim ide is a well-characterized in hibitor of eukar- 
yotic protein translation elongation (Gale et al., 1981). We 
therefore sought to ascertain that suppression resulted 
from direct effects of cycloheximide on protein synthesis, 
rather than from pleiotropic effects of the drug on an unre- 
lated target. To this end, we isolated mutations in ribo- 
somal protein L29, encoded by CYH2, which render cells 
resistant o higher levels of cycloheximide (St6cklein and 
Piepersberg, 1980). Such mutants arise spontaneously 
and can be readily selected by growing cells on plates 
containing cycloheximide. This allowed us to isolate cyh2 
mutant cells in the same strain background bearing the 
sec65-1 mutation. Cycloheximide-resistant colonies were 
isolated from strain RSY457 (sec65-1). One of these colo- 
nies was designated as strain SOY158 and chosen for 
further study. To confirm that the cycloheximide resis- 
tance of these cells was due to a mutation in CYH2, cells 
from strain SOY158 were crossed to strain 5114-2 bearing 
the cyh2 mutation. The resulting diploid strain was resis- 
tant to cycloheximide, and, after sporulation, the cyclohex- 
imide resistance phenotype segregated 4:0 in 20 tetrads 
analyzed, indicating that the cycloheximide resistance 
phenotype was due to a mutation in CYH2. Like the parent 
strain, SOY158 cells were temperature sensitive for 
growth. Growth of RSY457 (sec65-1, CYH2) cells at the 
permissive temperature was inhibited by 50% at 0.2 p.M 
cycloheximide, whereas growth of SOY158 (sec65-1, 
cyh2) cells was inhibited by 50% at 50 I~M cycloheximide 
(compare Figures 2B and 2C). We therefore conclude that 
SOY158 cells bear both the sec65-1 and the cyh2 muta- 
tions. 
To test whether cycloheximide would suppress the tem- 
perature-sensitive growth defect of SOY158 cells, we grew 
the cells in liquid culture at either the permissive or non- 
permissive temperature in the presence of increasing con- 
centrations of cycloheximide. As shown in Figure 2C, 
cycloheximide suppressed their growth defect at the non- 
permissive temperature; however, suppression required 
levels of cycloheximide 250-fold higher (100 ~M) than that 
required to suppress the growth defect of sec65-1 cells 
(Figure 2B). This difference correlated irectly with the 
resistance of SOY158 cells to a 250-fold higher level of 
cycloheximide when grown at he permissive temperatu re. 
These results strongly suggest that the ffects of cyclo- 
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heximide on translating ribosomes are directly responsible 
for the suppression of the defects caused by the sec65-1 
mutation. Furthermore, the defects caused by the sec65-1 
mutation must result from a loss of SRP, because they 
are only manifested in cells that initially harbor intact SRP. 
We can explain these results with the following model: in 
the presence of limiting concentrations of cycloheximide, 
nascent polypeptide chains emerge more slowly from the 
ribosome. This results in a longer time window during 
which the signal peptide of a nascent polypeptide chain 
can be recognized by SRP cotranslationally. Given this 
model, the cycloheximide-induced reduction of the elon- 
gation rate would allow a smaller, and otherwise insuffi- 
cient amount of SRP, to perform its normal function. 
We examined the fate of Sec65p in sec65-I cells to ask 
directly whether a small amount of Sec65p still remained 
after incubation at the nonpermissive temperature. To this 
end, we probed Western blots of lysates identical to those 
used for Figure 3 with antibodies specific for Sec65p. 
When shifted to 37°C, Sec65p levels fall to roughly 10% 
of those seen in cells grown at 24°C in the absence of 
cycloheximide (Figure 4A; compare lane 3 with lane 1). 
Growth in the presence of cycloheximide at 37°C further 
reduced the level of Sec65p, to roughly 5% of that seen 
in cells grown in the absence of cyclohexim ide (Figure 4A; 
compare lanes 4 and 6 with lane 1. Lane 6 contains ten 
times the amount of cell extract as lane 4). This reduced 
level of Sec65p in cycloheximide-treated cells grown at 
3Z°C was the same whether the cells were tested at 30 
min or 1.5 hr after a shift to 37°C (data not shown). These 
results show that a small amount of Sec65p remains in 
cells, even after prolonged incubation at the nonpermis- 
sive temperature, and thus are consistent with the model 
presented above. The data also rule out the alternative 
possibility that Sec65p is somehow being stabilized by 
cycloheximide at the nonpermissive temperature. 
According to another possible mechanism of suppres- 
sion, cycloheximide treatment might cause detrimental 
precursor proteins to be degraded or would induce an 
SRP-independent, posttranslational translocation path- 
24 °C 37  °C 
CHX:  r _ + 1 r _ + 1 
DPAP-B  - 
p reDPAP-B  - 
1 2 3 4 
lane  
Figure 3. Cycloheximide Suppresses the Protein Translocation De- 
fect of sec65-1 Cells 
RSY457 (sec65-1) cells growing at the indicated temperatures in the 
presence (lanes 2 and 4) or absence (lanes I and 3) of 0.4 pM cyclohexi- 
mide were pulse labeled with [~S]methionine for 7 rain. Cell extracts 
were immunoprecipitated with antibodies against either Kar2p or 
DPAP-B. The precursor and mature forms of each of the immunopre- 
cipitated proteins are indicated. Immunoprecipitated proteins were vis- 
ualized by autoradiography following SDS-PAGE. 
A 24 'C  37  °C 37  °C 
CHX:  r _  + 1 i _ +1 r _ + 1 
Load:  1X IX  1X 1X 10X 10X 
1 2 3 4 5 6 
60-  _ + _ + CHX 
50  
~ 40 
~ 3o 
~ 2o 
0 32  
chase  t ime ( ra in )  
Figure 4. Cycloheximide Does Not Stabilize Sec65p or Increase the 
Efficiency of Protein Translocation i to the ER 
(A) Lysates made from cells grown as in Figure 3 were subjected to 
Western blot analysis. Lanes 1-4 contain 0.50D~ cell equivalents 
of lysate. Lanes 5 and 6 are duplicates of lanes 3 and 4, except that 
5.00D~ cell equivalents of lysate were loaded. The position of Sec65p 
is indicated with an arrow. 
(B) RSY457 (sec65-1) cells were shifted from 24°C to 37°C for 30 min 
prior to pulse labeling for 1 min with [~S]methionine. Concomitant 
with the addition of nonradiolabeled methionine ina 1O0O-fold molar 
excess, cycloheximide was added to cells as indicated. Cells were 
incubated for 0 or 32 rain and then processed for immunoprecipitation 
using anti-Kar2p. Kar2p and pre-Kar2p were separated by SDS-PAGE 
followed by quantitation on a Phosphorlmager. 
way. To test these possibilities, we accumulatecl radiola- 
beled precursor proteins by shifting sec65-1 cells to 37°C 
followed by pulse labeling with [3sS]methionine. After the 
addition of a large excess of unlabeled methionine, the 
incubation was continued at 37°C in either the presence 
or the absence of cycloheximide, and the fate of labeled 
pre-Kar2p was monitored. Aliquots of the cell culture were 
removed at the intervals indicated in Figure 4B and immu- 
noprecipited with antibodies to Kar2p. As demonstrated 
by the results shown in Figure 4B, pre-Kar2p was stable 
throughout the duration of a 32 min chase period, regard- 
less of the presence or absence of cycloheximide. Be- 
cause the time needed for cycloheximide to exert its effect 
is no longer than 10 min (conditions under which the exper- 
iment in Figure 3 was performed), we know that the tem- 
perature-induced protein translocation defect can be sup- 
pressed by cycloheximide during the first third of the chase 
period shown in Figure 4B. Thus, we can conclude that the 
suppression of the translocation defect shown in Figure 3 
was not simply due to precursor degradation, nor was it 
caused by the precursors being trdnslocated in a post- 
translational manner. 
To test the validity of our model, we used an independent 
approach, not involving the sec65-1 mutation, to reduce 
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(B) Immunoprecipitations were performed with anti-Kar2p antibodies. 
Figure 5. ProteinTranslocation DefectsCaused 
by SRP Depletion Are Suppressed by Cyclo- 
heximide 
BHY104 cells containing SRP54 under the con- 
trol of the GALl promoter were shifted from 
galactose to glucose to repress the expression 
of Srp54p. At the indicated time points after 
repression of Srp54p, samples were incubated 
in the presence (bottom in [A] and [B]) or ab- 
sence (top in [A] and [B]) of cycloheximide for 
5 min. Cells were pulse labeled with Trans[~S]- 
label for 15 min, followed by a 2 min chase 
period to complete processing of all K r2p 
chains. Kar2p and pre-Kar2p were visualized 
as in Figure 3. Higher levels of Kar2p at later 
time points are due to the induction of the heat 
shock response upon accumulation of cyto- 
plasmic precursors (Arnold and Wittrup, 1994). 
(A) Portions of the radiolabeled extracts were 
subjected to Western blot analysis with anti- 
Srp54p antibodies. Each lane contains 0.5 
OD~ cell equivalents of lysate and contained 
equivalent amounts of protein as judged by 
Ponceau S staining. 
(C) Quantification of the data in (B) was performed on a Phosphorlmager. Squares, minus CHX; circles, plus CHX. 
(D) In a similar but separate experiment, cycloheximide (squares) and anisomycin (circles) were titrated after cells were grown for 11hr in glucose 
medium to deplete Srp54p. After incubation of the cells for 5 min with the indicated amount of each drug, cells were processed as above, and 
the ratio of pre-Kar2p to Kar2p was determined. The concentration range of each drug was chosen on the basis of the data in Figure 2. In the 
absence of the drug, 40% pre-Kar2p accumulated, compared with only 25% at the corresponding time point in (C). This is due to variation among 
separate xperiments. 
the amount of functional SRP in cells and then monitored 
the effects of cycloheximide on the efficiency of protein 
translocation. Strain BHY104 contains SRP54 under the 
control of the GALl  promoter, and SRP can be depleted 
from these cells by switching the carbon source from ga- 
lactose- to glucose-containing media (Figure 5A). As 
shown previously, precursors of normally translocated 
proteins accumulate as the concentration of SRP be- 
comes limiting in these cells (Hann and Walter, 1991). 
Thus, monitoring the efficiency of protein translocation at 
different imes after repression of Srp54p synthesis, i.e., 
in cells containing decreasing concentrations of SRP, al- 
lowed us to test directly whether a reduction of the elonga- 
tion rate by cycloheximide would allow a limiting concen- 
tration of SRP to work more efficiently. To perform this 
experiment, aliquots were taken from a culture of BHY104 
cells at different imes after repression of SRP54 and incu- 
bated both in the presence and absence of cycloheximide 
for 5 rain. [35S]Methionine was then added to pulse label 
newly synthesized proteins. We examined the accumula- 
tion of pre-Kar2p in cells labeled in the absence or pres- 
ence of cycloheximide after immunoprecipitation. 
Pulse labeling in the absence of cycloheximide gave the 
expected results (Figure 5B, top, and Figure 5C, squares). 
Pre-Kar2p started to accumulate at 9 hr after SRP54 ex- 
pression was repressed and reached a plateau at 13 hr 
at about 40% of the total immunoprecipitated Kar2p spe- 
cies. In contrast, in the presence of cycloheximide, the 
accumulation of pre-Kar2p was significantly delayed (Fig- 
ure 5B, bottom, and 5C, circles), indicating that cyclohexi- 
mide allowed the limiting concentration of SRP in these 
cells to work more efficiently. As shown in the Western blot 
analysis in Figure 5A, the delay of pre-Kar2p accumulation 
was not due to differences in Srp54p levels in the untreated 
and cycloheximide-treated samples. While the pre-Kar2p 
accumulation in the presence of cycloheximide was signifi- 
cantly reduced at the 9-13 hr time points, it eventually 
reached the same plateau as in the absence of cyclohexi- 
mide. This result is expected, because cells must switch 
from an SRP-dependent mode of protein translocatiomto 
an SRP-independent mode when SRP is depleted. From 
the data shown in Figure 5C, we surmise that between 9 
and 11 hr after repression of Srp54p synthesis, the levels 
of functional SRP become limiting but are still high enough 
to afford efficient protein translocation, ifthe rate of protein 
elongation is reduced by cycloheximide. At the later time 
points, however, an increasing fraction of Kar2p becomes 
targeted through the SRP-independent pathway and, be- 
cause the level of functional SRP becomes too low, effi- 
cient cotranslational SRP-dependent protein translocation 
can no longer be reinstated, even if the elongation rate is 
reduced by the addition of cycloheximide. Consistent with 
this interpretation, the growth and protein translocation 
defects in strains deleted for SRP54 or SEC65 cannot be 
abrogated by the addition of cycloheximide (data not 
shown). 
To determine the concentration of cycloheximide that 
would give the greatest difference of precursor accumula- 
tion, we performed a titration experiment with cells taken 
from a fixed time point (11 hr after shift to glucose) in the 
SRP depletion experiment. The results show that increas- 
ing amounts of cycloheximide progressively improved 
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translocation efficiency (Figure 5D, squares), indicating 
that the more protein elongation is slowed, the more effi- 
ciently protein translocation occurs in the presence of a 
fixed concentration of SRP. The optimum cycloheximide 
concentration was found to be 1.6 I~M. The difference be- 
tween this concentration and the one required to suppress 
the growth defect of sec65-1 cells (0.4 p.M) may be due 
to differences in the strain background between RSY457 
(sec65-1) and BHY104 (pGALSRP54) cells. Alternatively, 
the optimal concentration of cycloheximide that allows effi- 
cient Kar2p translocation in a 5 min pulse (conditions in 
Figure 5) may not allow sustained growth of yeast in liquid 
culture (conditions in Figure 2). 
According to our model, the nascent protein chain has to 
emerge from the ribosome more slowly to allow a reduced 
concentration of SRP to target the nascent chains cotrans- 
lationally. If this is the case, then inhibiting protein synthe- 
sis initiation should not suppress the sec65-1-induced 
growth defects, because, while reducing the flux of newly 
synthesized protein, this would not reduce the rate at 
which they emerge from the ribosome. To reduce transla- 
tion initiation, we expressed dominant, constitutively ac- 
tive alleles of GCN2 in either sec65-1 or wild-type cells. 
Gcn2p is a protein kinase that inactivates initiation factor 
elF-2a by phosphorylation, and cells expressing dominant 
alleles of GCN2 grow at reduced rates because of limiting 
concentrations of active elF-2a. The severity of the growth 
defect correlates with the degree to which the mutations 
in.GCN2 activate its kinase activity (Dever et al., 1992). 
We expressed the wild-type and three constitutively active 
alleles of GCN2 (in increasing strengths, GCN2C-516, 
GCN2C-518, and GCN2C-515) in either sec65-1 or wild-type 
cells. Figure 6A depicts plates on which either sec65-1 or 
wild-type cells were grown at 24°C or 37°C. The particular 
allele of GCN2 that was present in the cells in each quad- 
rant of the plates is indicated below. To quantitate the 
severity of the growth defect produced by each of the dif- 
A sec65-1 SEC65 B 
24 ° C 
37 ° C 
0,5, 
0.4- 
.~ 0.2- 
o 
~ 0.4- 
g 0.3- 
.~ 0.2- 
.~ o.1- 
o 
ferent GCN2 c alleles, we measured the growth rates of 
cells in liquid culture under the conditions shown in Fig- 
ure 6A. 
None of the GCN2 alleles suppressed the sec65-1 
growth defect at the nonpermissive temperature (Figure 
6A), even though the growth of sec65-1 cells expressing 
the GCN2C-515 allele was more than 4-fold reduced com- 
pared with that of cells bearing the wild-type GCN2. This 
is a similar fold reduction in growth rate to that caused by 
the presence of 0.4 I~M cycloheximide (compare Figure 
6B with Figure 2B), which caused suppression. Thus, a 
reduction of the overall protein synthesis rate is not suffi- 
cient to suppress the sec65-1 growth defect; rather, a re- 
duction in the rate of protein elongation is required. 
To determine whether defects in cells containing limiting 
amounts of SRP can be suppressed by slowing translation 
elongation at any point in the elongation cycle, we tested 
an additional drug, anisomycin, which inhibits the trans- 
peptidylation reaction (Gale et al., 1981). Surprisingly, in 
contrast with cycloheximide, anisomycin was unable to 
suppress the growth defect of sec65-1 cells at 37°C (see 
Figure 2D, closed circles). Similarly, anisomycin was un- 
able to suppress the translocation defect at early times 
after Srp54p depletion (see Figure 5D, circles). Aniso- 
mycin was able, however, to enter yeast cells efficiently 
and inhibit growth of sec65-1 cells at the permissive tem- 
perature (see Figure 2D, squares). 
These results raised the possibility that the different ef- 
fects of cycloheximide, anisomycin, and the GCN2 c muta- 
tion could, in principle, result from differential effects of 
these three inhibitors on the translation of individual 
mRNAs. Translation of a subset of proteins could, for ex- 
ample, be irreversibly blocked in one case but not another, 
and the different effects leading to the suppression of the 
translocation defect under conditions of limiting SRP 
might then result from the different spectrum of proteins 
synthesized. To test for this possibility directly, we deter- 
37°C 
a 
SEC65 
37°C 
Figure6. Inhibition of Translation Initiation 
Does Not Suppress the Growth Defect of 
sec65-1 Cells 
(A) RSY457 or W303-1A cells (either sec65.1 
or SEC65) were transformed with plasmids con- 
taining the indicated ominant allele of GCN2. 
These cells were grown on media selecting for 
the plasmid at either 24°C or 37°C. The dia- 
gram illustrates which quadrant of each plate 
contains cells harboring the indicated allele of 
GCN2. 
(B) The growth rates of the strains used in (A) 
were determined. The average of two separate 
experiments i shown. 
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Figure 7. Translation Elongation and Initiation Inhibitors Affect the 
Same Spectrum of Proteins 
(A) Incorporation of [~S]methionine at 24°C is plotted as a function 
of time. sec65-1 cells were pulse labeled in the absence (open squares) 
or presence (open circles) of either cycloheximide (plus CHX) or aniso- 
mycin (plus AN M). At the indicated times after [~S]meth ionine addition, 
hot TCA-precipitable counts in aliquots containing equal OD~ cell 
equivalents were measured by scintillation counting. W303 cells con- 
taining a plasmid bearing wild-type GCN2 (open squares) or the domi- 
nant allele GCN2C-515 (open circles) were treated identically (GCN2 c- 
S15). 
(B) Aliquots (0.10D~ cell equivalents per lane) from lysates prepared 
at the 130 s time point from the labeling reaction shown in (A) were 
subjected to SDS-PAGE, followed by scanning of the lanes with a 
Phosphorlmager. The positions of molecular mass markers are indi- 
cated below each panel. In each panel, the top trace is that obtained 
in the absence of inhibitor, while the bottom trace is obtained from 
cell lysate labeled in the presence of either cyctoheximide (plus CHX), 
anisomycin (plus ANM), or the dominant negative allele of GCN2 
( GCN2C.515). 
mined the effects of cycloheximide, anisomycin, and the 
GCN2C-515 mutation on the overall pattern of proteins syn- 
thesized. To this end, we monitored the rate of incorpora- 
tion of [3sS]methionine into protein in the absence or in 
the presence of the three inhibitors under conditions that 
were shown in Figures 2 and 6 to slow cell growth to ap- 
proximately similar extents (Figure 7A). Incorporation of 
[3~S]methionine was linear over the course of the 3 rain 
experiment, and its rate was decreased by about 25% in 
the presence of the inhibitors. We chose a late time point 
(130 s) from this labeling reaction to analyze the pattern 
of newly synthesized proteins in the presence of the three 
inhibitors. Total labeled cell protein was fractionated by 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE), 
and the lanes were scanned along their lengths with a 
Phosphorlmager (Figure 7B). In each case, the upper 
trace represents the profile of proteins synthesized in the 
absence of inhibitor, while the lower trace represents the 
profile of proteins synthesized in the presence of inhibitor. 
These results show that all three inhibitors diminish uni- 
formly the incorporation of [35S]methionine across the en- 
tire spectrum of the labeled protein species. From these 
data, we conclude that the observed differences between 
the inhibitors most likely result because they affect differ- 
ent steps of protein translation and not because they have 
differential effects on the translation of individual mRNAs. 
Discuss ion  
We have shown that growth and protein translocation de- 
fects induced in yeast cells containing limiting concentra- 
tions of SRP can be suppressed by slowing protein elonga- 
tion with low concentrations of cycloheximide. Two 
independent means of lowering SRP levels were used: 
shifting sec65-1 cells to the nonpermissive temperature 
and depleting Srp54p after transcriptional repression. 
Cycloheximide ameliorates growth and translocation de- 
fects in both cases, but not after prolonged Srp54p deple- 
tion or in cells bearing complete SRP gene disruptions, 
indicating that some residual SRP must be present in cells 
for cycloheximide to exert this effect. Furthermore, cyclo- 
heximide-resistant cells harboring a mutation in ribosomal 
protein L29 (encoded by CYH2) require significantly higher 
concentrations of cycloheximide to affect suppression, 
thereby demonstrating that suppression is mediated di- 
rectly through the effects of cycloheximide on the ribosome. 
These observations trongly support a model in which 
cycloheximide causes nascent polypeptide chains to 
emerge more slowly from the ribosome, creating a longer 
time window during which the signal peptide of a nascent 
polypeptide chain can be recognized by SRP and targeted 
to the ER membrane cotranslationally. Thus, the cyclohex- 
imide-induced reduction of the elongation rate allows a 
limiting amount of SRP to perform its normal function. 
Consistent with this model, we found that inhibition of 
translation initiation (experimentally induced by the intro- 
duction of the GCN2 c mutations, Figure 6) does not cause 
suppression. Unexpectedly, another well-characterized 
inhibitor of translation elongation, anisomycin, also failed 
to cause suppression, indicating that slowing down the 
rate of protein elongation per se is not sufficient to sup- 
press defects caused by low levels of SRP. Anisomycin 
blocks transpeptidylation, while cycloheximide blocks trans- 
location, which is the eEF2-catalyzed movement of pepti- 
dyl-tRNA from the A site to the P site (Figure 8C). These 
data suggest that SRP can interact productively with ribo- 
somes and signal sequence-bearing nascent chains only 
at a specific step(s) in the elongation cycle, which is the 
step at which ribosomes accumulate in the presence of 
cycloheximide. 
The notion of an intimate, elongation step-specific inter- 
action of SRP and the ribosome suggests a mechanism 
that can explain how SRP selects signal sequence-bear- 
ing ribosomes from the total ribosomal pool. Estimation 
of the concentration of SRP mammalian cells, yeast (B. C. 
Hann and P. W., unpublished data), and E. coil (Jensen 
and Pedersen, 1994) suggest that there is one SRP for 
every 10-100 translating ribosomes. SRP has to scan ev- 
ery nascent chain for the presence of a signal sequence, 
yet, on the basis of the estimated SRP levels, only a small 
fraction of the translating ribosomes can have an SRP 
associated at any one time. On the basis of the results 
presented here, SRP can inte'ract with ribosomes only dur- 
ing a specific step in the translation cycle. This is consis- 
tent with a sampling mechanism in which SRP is con- 
stantly cycling on and off the ribosome, as opposed to a 
scanning mechanism in which SRP. would remain ribo- 
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Figure 8. Model for SRP Interaction i  the Translational Cycle 
Translation is hown as a cycle of translational e ongation preceded 
by initiation (blocked by GCN2 c alleles) and followed by termination. 
Translational elongation is simplified in this model as consisting of 
three steps: aminoacyl-tRNA binding to the ribosomal A site (A), trans- 
peptidylation (B), and transiocation of the p ptidyl-tRNA from the A 
site to the P site (C). SRP interacts with the ribosome-nascent chain 
complex after the anisomycin block but before the cycloheximide 
block. This model is adapted from the hybrid sites model of transla- 
tional elongation as proposed by Moazed and Noller (1989). 
some associated. We propose that SRP binds to the 
translating ribosome when it has just completed the trans- 
peptidylation reaction, but before it has undergone translo- 
cation of the peptidyl-tRNA from the A site to the P site. 
While bound, the SRP checks whether the emerging na- 
scent protein contains a signal sequence. If this is the 
case, SRP targets the ribosome to the ER membrane; if 
no signal sequence is found, SRP dissociates, and the 
ribosome continues through the elongation cycle. Ac- 
cording to this mechanism, a substoichiomet ric concentra- 
tion of SRP would suffice to monitor each ribosome for 
the presence of a signal sequence. Because SRP can 
recognize signal sequences on nascent chains of different 
lengths, we surmise that sampling need not occur during 
every elongation cycle (Siegel and Walter, 1988). 
Concomitant with a tighter association of SRP to the 
ribosome, elongation pausing is observed upon binding 
of SRP to a signal sequence (Walter and Blobel, 1981). 
This suggests that SRP dissociation is obligatory for the 
ribosome to resume elongation. According to this model, 
it should be possible to isolate SRP mutants that inhibit 
protein synthesis because they bind inappropriately tightly 
to ribosomes. 
The definition of the point of action of SRP during the 
translation elongation cycle is in agreement with results 
obtained in prokaryotic ells. In E. coli, the SRP RNA ho- 
molog 4.5S RNA and the Srp54p homolog Ffh are essen- 
tial for cell growth (Brown and Fournier, 1984; Phillips and 
Silhavy, 1992). Prior to results suggesting its SRP-like role 
in protein secretion, 4.5S RNA was proposed to be directly 
involved in translation (Brown, 1987; Brown and Fournier, 
1984). In particular, suppressor mutations were isolated 
in components of the translation apparatus that allowed 
cells to grow even though they contained sublethal evels 
of 4.5S RNA. Suppressor mutations were found in elonga- 
tion factor G (EF-G, the prokaryotic homolog of eEF-2), in 
23S ribosomal RNA in the region defining the EF-G- 
binding site, and in tRNA synthetases, resulting in higher 
levels of some uncharged tRNAs (Brown, 1987; Brown, 
1989). Intriguingly, these mutations are predicted to impair 
the translation cycle at the translocation step of peptidyl- 
tRNA from the A to the P site. EF-G mutants and mutations 
in the ribosomal EF-G-binding site would impair transloca- 
tion directly, whereas uncharged tRNAs might bind to the 
tRNA exit site (E site) on the ribosome, thereby backing 
up the ribosome to prevent ranslocation. These mutations 
suppressed defects caused by lowering the concentration 
of 4.5S RNA, but no mutations could be isolated that would 
allow cells to live in its absence. Brown (1989) concluded 
that 4.5S RNA participates in an event required for ribo- 
somal translocation. 
The results presented here and the increasing evidence 
pointing at an SRP-like role for the Ffh/4.5S RNP suggest 
a different interpretation for these data. We surmise that 
the lowered levels of 4.5S RNA resulted in lowered levels 
of functional SRP in E. coli, strictly analogous to the experi- 
mental scenarios described here in yeast. Mutations that 
slow the translocation step would therefore suppress the 
defects caused by reduced SRP levels, because of an 
increase in the time window in which SRP can productively 
recognize a signal sequence. Our data are in agreement 
with evidence suggesting that the E. coli Ffh/4.5S RNP 
indeed functions as a prokaryotic SRP. 
Experimental Procedures 
Strains, Plasmids, Antibodies, and General Methods 
Yeast strains used in this study are/isted in Table 1. Anti-DPAP-B 
serum was provided by T. Stevens, University of Oregon; anti-Sec65p 
is described by Brown et al. (1994); anti-Srp54p is described by Hann 
and Walter (1991); anti-Kar2p was produced in our laboratory from 
protein overexpressed in E, coil from a clone provided byJ. Vogel 
and M. Rose (Princeton University). SDS-PAGE was performed on 
10%-15% gradient gels, and Western blots were visualized by en- 
hanced chemiluminescence (ECL; Amersham Corporation, Arlington 
Heights, IL) according to the instructions of the manufacturer. Plasmid 
pSCR1 was constructed by ligating the SCR1 containing Kpnl to Hindlll 
fragment from pSR6.21 into the KpnI-Hindlll sites of pRS316 (Felici 
et al., 1989), 
Strain SOY288, containing both the s c65.1 and the scrl-A2 muta- 
tions, was constructed by mating strain RSY457 to strain BHY133. 
Sporulation of the resulting diploid followed by tetrad dissection al- 
lowed the identification of tetrads that contained colonies resulting 
from two of the four spores with the SEC65, SCR1 genotype. These 
colonies were identified, because they were not temperature s nsitive 
and grew at wild-type rates. Wetherefore reasoned that colonies re- 
sulting from the other two spores must contain both the sec65-1and 
sorl-A2 mutations. Presence of scr1-.42 was confirmed by the slow 
growth phenotype of the cells, Confirma~on that these cells also c n- 
tained the sec65-1 mutation was achieved by transformation f the 
cells with a plasmid (pSCR1) bearing wild-type SCR1, resulting in the 
recovery of the temperature-sensitive phenotype as shown in Figure 1. 
Strain SOY158, containing both sec65-1 and cyh2 mutations, was 
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Table 1. Yeast Strains 
Strain Genotype Source 
RSY457 
W303-1A 
CSY186 
BHY104 
BHY133 
SOY158 
SOY288 
5114-2 
MATa sec65-1, ura3-52, ade2-1, trp l-zJ l, leu2-3-112, his3 
MATa ura3-1, ade2-1, trpl-1, leu2-3-112, his3-11, can1-100 
MATcz trpl, lys2, his3, ura3, ade2, sec65::HIS3 
MATa trpl, lys2, his3, ura3, ade2, srp54-Lt1, (pGALSRP54) 
MATa trpl, lys2, his3, ura3, ade2, scrl::HIS3 [rho-] 
MATa sec65-1, cyh 2, ura3- 52, ade2-1, trp l-zt l , leu2-3.112, his3 
MAT~ sec65-1, scrl-A2, his3, ura3, trpl 
MAT~ leu2-3-112, ura3-52, trp1-289, hisT, hem3, can1, chy2, gall 
Stirling et al. (1992) 
R. Rothstein, Columbia University 
Stirling and Hewitt (1992) 
Hann and Walter (1991) 
Brown et al. (1994) 
This study 
This study 
N. Hollingsworth, State University of New York 
at Stonybrook 
constructed in the following manner. RSY457 cells were plated onto 
YEPD plates containing 10 mg/ml of cycloheximide. From approxi- 
mately 108 cells, we recovered three cycloheximide-rasistant colonies. 
One of these colonies was designated SOY158. That the cyclohexi- 
mide-resistant phenotype resulted from a mutation at the CYH2 locus 
was confirmed by crossing strains SOY158 and 5114-2. The resulting 
diploid was able to grow on cycloheximide plates, indicating that what- 
ever mutation had occurred did not complement the cyh2 mutation of 
5114-2. Colonies resulting from the sporulation and subsequent etrad 
dissection (20 tetrads analyzed) of the diploid strain SOY158 x 5114-2 
were all resistant to high concentrations of cycloheximide. 
Sequencing of the sec65-1 Allele 
Plasmid pJDY32 was constructed by polymerase chain reaction (PCR) 
using oligonucleotides complementary to bases -336 to -354 on the 
N-terminal end of the SEC65 gene and +1051 to +1068 on the C-ter- 
minal side, and pCS52 as template DNA (Stirling and Hewitt, 1992). 
The PCR product was ligated into the Smal site of pRS314 (Sikorski 
and Heiter, 1989). We recovered the sec65-1 allele from RSY457 by 
gap repair (Orr-Weaver et al., 1988). Toward this end, pJDY32, con- 
taining the entire coding sequence of SEC65, as well as TRP1, CEN, 
and ARS sequences, was digested with the restriction enzymes Nhel 
and Ndel, which cut at two unique sites to remove a portion of the 
SEC65 gene. The gap begins 63 nt upstream of the A of the initiating 
codon and continues through the last nucleotide of codon 207, remov- 
ing a fragment hat encodes 207 of the 273 amino acids of the SEC65 
gene. The resulting vector fragment was transformed into strain 
RSY457 (sec65-1). Eight Trp* colonies failed to grow at 37°C, indicat- 
ing that they were not able to complement he sec65-1 temperature- 
sensitive growth defect. Plasmids were isolated from two of these 
colonies, amplified in bacteria, and shown to contain the entire SEC65 
gene. The plasmids were transformed into strain CSY186 (sec65:: 
HIS3). Trp ÷ transformants were tested for their ability to complement 
the growth defect of the deletion allele. Deletion of any of the compo- 
nents of the SRP pathway results in a 3- to 5-fold reduction in the growth 
rate of the cells containing the deletion. Two plasmids, pSO438-1 and 
pSO438-2, restored temperature-sensitive growth to cells containing 
the sec65 deletion (CSY186) but failed to complement the temperatura- 
sensitive growth of the original sec65-1 mutation (RSY457). Thus, we 
concluded that the plasmids contain the mutation that causes the 
sec65.1 temperature-sensitive growth. Because the sec65-1 allele was 
repaired to a gapped plasmid, the mutation must occur within the 
boundaries of the gap. The DNA sequences of pSO438-1, pSO438-2, 
and pJDY32 were determined between these two restriction sites on 
both strands. Both pSO438-1 and pSO438-2 contained the same single 
• basechangewhencomperadwiththesequenceofpJDY32.Thisdiffer- 
ence was a C to T transition at position 795 of the coding strand. This 
occurs in the second position of codon 152 and is predicted to change 
a proline codon (CCA) in the wild-type allele of SEC65 to a leucine 
codon (CTA) in the sec65-1 mutant allele. Ethyl methanesulfonate, 
the mutagen used in the selection that yielded sec65-1, is known to 
produce this type of mutation. 
Cell Labeling and Immunoprecipitations 
Radiolabeling and immunoprecipitations were performed as described 
by Ogg et al. (1992). The pulse-chase experiment shown in Figure 4 
was performed by pulse labeling cells for 2 min at 30°C with 60 i~Ci/ 
OD~ Tran[35S]-Iabel (ICN Biomedicals, Costa Mesa, CA) followed by 
the addition of a 1000-fold molar excess of nonradiolabeled methio- 
nine, and cycloheximide at 0.4 I~M to one of two aliquots. The tubes 
were incubated at 30°C for the duration of the 32 rain chase period. 
Aliquots containing 50D~ cell equivalents were processed for immu- 
noprecipitation at both the O and 32 rain time points. Following immuno- 
precipitation with anti-Kar2p antibodies, immunopracipitated proteins 
were visualized and quantified by SDS-PAGE followed by analysis 
with a Phosphorlmager (Molecular Dynamics, Sunnyvale, CA). 
Quantitation of the rate of [~S]methionine incorporation was per- 
formed by labeling sec65-1 cells for 200 s at 24°C with 30 p.Ci/OD~ 
Tran[~S]-Iabel, in the presence of a 50-fold excess of nonradioactive 
methionine to prevent depletion of methionine during the experiment. 
Analysis of the media after removal of the cells confirmed that during 
the time course of this experiment, he external pool of [~S]methionine 
remained unchanged. An exponentially growing culture of sec65-1 
cells was split into three I~ortions; ANM (10 p.M) and CHX (0.4 p.M) 
were each added to a separate portion, while the third served as a 
control. These cultures were incubated at 24°C for 10 rain prior to 
initiating the labeling experiment. In addition, cells containing either 
wild-type GCN2 or GCN2C-515 on a plasmid were subjected to the 
same analysis. At different ime points, aliquots of cells were plunged 
into ice-cold 10% trichloroacetic acid ('I'CA) and lysed immediately 
in the presence of a two-thirds volume of zirconium beads (Biospec 
Products, Bartelseville, OK) by use of a benchtop vortex. The lysates 
were incubated at 10O°C for 10 rain in 10% TCA to discharge any 
methionyl-tRNAs containing [~S]methionine. After TCA precipitation, 
proteins were solubilized in SDS sample buffer and subjected to scintil- 
lation counting or SDS-PAGE analysis. 
Growth of Cells on Cycloheximide and Anisomycin 
Sterile filter disks containing 6 nmol of cycloheximide in distilled water 
were placed on YEPD plates. In hqutd culture, YEPD was supple- 
mented with the indicated concentration of cycloheximide or anise- 
mycin. Cycloheximide was prepared as a 100 mM stock solution in 
distilled water and sterilized by passage through a 0.2 p.m filter. Aniso- 
mycin was prepared in a similar manner as a 7.5 mM stock solution 
in 70% ethanol. 
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